Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer

被引：0
|
作者：
Grassadonia, Antonino
Cianchetti, Ettore
Ficorella, Corrado
Angelucci, Domenico
Grossi, Simona
Ricevuto, Enrico
Zilli, Marinella
Tinari, Nicola
Natoli, Clara
Iacobelli, Stefano
机构：
[1] Univ G DAnnunzio, Breast Surg Unit, Chieti, Italy
[2] Univ Aquila, I-67100 Laquila, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [1] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer.
    Natoli, C.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Noccioli, P.
    Ricevuto, E.
    Grassadonia, A.
    Zilli, M.
    Di Giacobbe, A.
    Rispoli, A., I
    Tinari, N.
    Iacobelli, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S150 - S150
  • [2] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with stage II/IIIA breast cancer
    Iacobelli, S.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Noccioli, P.
    Ricevuto, E.
    Rispoli, A.
    Castrilli, G.
    Grassadonia, A.
    Zilli, M.
    Tinari, N.
    Di Giacobbe, A.
    Natoli, C.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI5 - XI6
  • [3] Preoperative sequential chemotherapy of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with stage II/IIIA breast cancer
    Grassadonia, A.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Ricevuto, E.
    Zilli, M.
    Tinari, N.
    Natoli, C.
    Iacobelli, S.
    [J]. BREAST, 2007, 16 : S48 - S48
  • [4] Preoperative dose-dense sequential chemotherapy of epirubicin/ cyclophosphamide followed by docetaxellcapecitabine in patients with early breast cancer: preliminary results
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 158 - 158
  • [5] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophosphamide followed by docetaxel in primary breast cancer.
    Cramer, EM
    Moers, C
    Zarghooni, V
    Mallmann, P
    Warm, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 82S - 82S
  • [6] Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
    Mirzaei, Hamid Reza
    Rasekh, Parisa Sabet
    Nasrollahi, Fatemeh
    Rasekh, Parto Sabet
    Tirabad, Zahra Akbari
    RezaMoein, Hamid
    Pour, Taban Ghaffari
    Hajian, Parastoo
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [7] Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
    Nieto, Yago
    Manuel Aramendia, Jose
    Espinos, Jaime
    De la Cruz, Susana
    Fernandez-Hidalgo, Oscar
    Santisteban, Marta
    Arbea, Leyre
    Aristu, Javier
    Martinez-Monge, Rafael
    Moreno, Marta
    Pina, Luis
    Sola, Josu
    Zornoza, Gerardo
    Martinez Regueira, Fernando
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 457 - 465
  • [8] Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
    Yago Nieto
    José Manuel Aramendía
    Jaime Espinós
    Susana De la Cruz
    Oscar Fernández-Hidalgo
    Marta Santisteban
    Leyre Arbea
    Javier Aristu
    Rafael Martínez-Monge
    Marta Moreno
    Luis Pina
    Josu Sola
    Gerardo Zornoza
    Fernando Martínez Regueira
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 65 : 457 - 465
  • [9] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophoshamid followed by docetaxel in primary breast cancer
    Cramer, EM
    Moers, C
    Zarghooni, V
    Bosse, K
    Mallmann, P
    Warm, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S231 - S231
  • [10] Neoadjuvant dose-dense sequential biweekly epirubicin and cyclophosphamide followed by docetaxel and trastuzumab for HER2+operable breast cancer
    Blakely, L.
    Somer, B.
    Keaton, M.
    Hermann, R.
    Schnell, F.
    Cobb, P.
    Johns, A.
    Walker, M.
    Schwartzberg, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345